Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Institute of Medical Genetics and Applied Genomics, |
RCV001268784 | SCV001447965 | pathogenic | not provided | 2020-10-23 | criteria provided, single submitter | clinical testing | |
Genome Medicine, |
RCV002275334 | SCV002562760 | pathogenic | KBG syndrome | criteria provided, single submitter | clinical testing | KBG syndrome | |
Genetics and Molecular Pathology, |
RCV002275334 | SCV004175524 | pathogenic | KBG syndrome | 2023-06-13 | criteria provided, single submitter | clinical testing | The ANKRD11 c.2329_2332del variant is classified as Pathogenic (PVS1, PS4_Supporting, PM2) This ANKRD11 c.2329_2332del variant is located in exon 9/13 and is predicted to cause a shift in the reading frame at codon 777, leading to the introduction of a premature stop codon (PVS1). The variant has been reported once in a proband with a clinical presentation of KBG Syndrome (PMID:35970914) (PS4_Supporting). This variant is absent from population databases (PM2). The variant has been reported in the HGMD database: CD2216935 and has been reported as Pathogenic by other diagnostic laboratories (ClinVar Variation ID: 987422). It has not been reported in dbSNP. |